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Members of the CDM (CED-5, Dock180,Myoblast city) superfamily of guanine nucleotide exchange factors function in diverse processes that
include cell migration and myoblast fusion. Previous studies have shown that the SH3, DHR1 and DHR2 domains of Myoblast city (MBC) are
essential for it to direct myoblast fusion in the Drosophila embryo, while the conserved DCrk-binding proline rich region is expendable. Herein,
we describe the isolation of Drosophila ELMO/CED-12, an ∼82 kDa protein with a pleckstrin homology (PH) and proline-rich domain, by
interaction with the MBC SH3 domain. Mass spectrometry confirms the presence of an MBC/ELMO complex within the embryonic musculature
at the time of myoblast fusion and embryos maternally and/or zygotically mutant for elmo exhibit defects in myoblast fusion. Overexpression of
MBC and ELMO in the embryonic mesoderm causes defects in myoblast fusion reminiscent of those seen with constitutively-activated Rac1,
supporting the previous finding that both the absence of and an excess of Rac activity are deleterious to myoblast fusion. Overexpression of MBC
and ELMO/CED-12 in the eye causes perturbations in ommatidial organization that are suppressed by mutations in Rac1 and Rac2, demonstrating
genetically that MBC and ELMO/CED-12 cooperate to activate these small GTPases in Drosophila.
© 2007 Elsevier Inc. All rights reserved.Keywords: Drosophila; ELMO; MBC; Rac; Myoblast fusion; Ommatidial organizationIntroduction
Drosophila myoblast city (MBC), Caenorhabditis elegans
CED-5, and vertebrate DOCK180, are closely related members of
the evolutionarily conserved CDM family of proteins (Erickson et
al., 1997; Hasegawa et al., 1996; Wu and Horvitz, 1998b). They
serve as key players in a signaling complex that includes the SH2–
SH3 domain-containing adaptor protein CrkII/CED-2 and the PH
domain containing protein ELMO/CED-12 (reviewed in (Meller
et al., 2005)). This complex then acts at the membrane to relay
signals to the small GTPase Rac1/CED-10. MBC/DOCK180/
CED-5 function as non-conventional Guanine nucleotide Ex-
change Factors (GEFs) for Rac. Conventional GEFs bind to
nucleotide-free Rac via a Dbl-homology (DH) domain, thereby⁎ Corresponding author. Fax: +1 816 926 4693.
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doi:10.1016/j.ydbio.2007.11.022facilitating exchange of GDP for GTP. DOCK180/CED-5, which
lack DH domains, associate with nucleotide-free Rac through a
conserved Dock-Homology Region (DHR2) (Brugnera et al.,
2002; Cote and Vuori, 2002). Deletion of this domain results in
loss of Rac binding and the inability to direct formation of GTP-
bound Rac (Brugnera et al., 2002).
In addition to DHR2, CDM proteins have in common an N-
terminal SH3domain, a secondDockHomologyRegion (DHR1),
and a C-terminal proline rich region. The C-terminal region
directs interaction with the SH3 domain of CrkII/CED-2. The
CrkII SH2 domain can then direct interaction with upstream
proteins that are phosphorylated on tyrosine, such as transmem-
brane receptors and components of focal adhesions (Cheresh et
al., 1999; Kiyokawa et al., 1998). In addition to membrane
recruitment through Crk-related interactions, the C-terminal PH
domain of ELMO/CED-12 can also mediate its membrane
localization (DeBakker et al., 2004; Grimsley et al., 2004). The
DHR1 region of DOCK180, which binds to phosphatidylinositol
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membrane localization (Cote et al., 2005; Kobayashi et al.,
2001). The N-terminal SH3 domains of DOCK180 and CED-5
mediate interaction with the C-terminal proline-rich region of
ELMOandCED-12, respectively (Lu et al., 2004, 2005;Wu et al.,
2001). In vitro studies demonstrate that DOCK180 binding to Rac
can be sufficient for its activation (Cote et al., 2005), but that this
activation can be significantly enhanced by DOCK180 bound to
ELMO (Brugnera et al., 2002; Katoh and Negishi, 2003; Lu et al.,
2004). Thus, the DOCK180/ELMO complex is a key component
in CDM signaling to Rac.
In addition to extensive homology and conserved biochem-
ical interactions between the DOCK180/CED-5 and ELMO/
CED-12 protein families, complexes of these proteins perform
similar biological functions. For example, genetic studies have
shown that C. elegans CED-10 acts with CED-2/Crk, CED-5/
DOCK180 and CED-12/ELMO to promote cell migration of the
distal tip cells during development of the somatic gonad and
engulfment of cell corpses following apoptosis (Gumienny et
al., 2001; Kinchen et al., 2005; Wu and Horvitz, 1998a; Zhou et
al., 2001). Membrane targeted DOCK180 increases cell
spreading, and overexpression of wild-type DOCK180 in
mammalian cells enhances cell migration and phagocytosis of
apoptotic cells (Cheresh et al., 1999; Kiyokawa et al., 1998).
Lastly, a reduction in wild-type DOCK180 or overexpression of
mutant forms of DOCK180 decrease activated Rac and cause
defects in cell spreading and cell migration (Cote and Vuori,
2002; Katoh and Negishi, 2003; Kiyokawa et al., 1998).
As in C. elegans and vertebrates, Drosophila MBC interacts
genetically with other molecules required for CDM pathway
function. For example, mutations in mbc delay border cell
migration and influence PVR mediated F-actin accumulation in
the follicle cells during ovary development, reflecting its
proposed role in the PVR-Rac pathway (Duchek et al., 2001).
Studies utilizing RNAi constructs have demonstrated a genetic
interaction between MBC, Drosophila Crk (DCrk) and ELMO
in adult thorax closure (Ishimaru et al., 2004). In the Drosophila
eye, in which Rac is required for proper actin organization
(Chang and Ready, 2000), the effects of Rac1 overexpression
are suppressed by loss of one copy of mbc (Nolan et al., 1998).
Rac1 was initially implicated in myoblast fusion in the embryo
by the demonstration that overexpression of either dominant-
negative or constitutively-active Rac1 interferes with myoblast
fusion (Luo et al., 1994). More recently, loss-of-function studies
have established that Rac1 and Rac2 play a redundant but
essential role in this process. MBC is absolutely essential for
myoblast fusion (Hakeda-Suzuki et al., 2002), where it
colocalizes in founder myoblasts with the immunoglobulin
superfamily member Duf/Kirre (Chen and Olson, 2001). MBC
is also expressed in, and apparently required in, the fusion
competent myoblasts (Balagopalan et al., 2006). Structure/
function analysis of MBC identified the protein domains that
are essential for myoblast fusion. This analysis revealed that,
like Dock180, the DHR1 domain binds to PtdIns(3,4,5)P3 and is
essential for myoblast fusion. The N-terminal SH3 domain and
the putative Rac binding DHR2 domain are essential for MBC
transgenes to rescue the myoblast fusion defects in mbc mutantembryos. Surprisingly, however, while the C-terminal proline-
rich region directs a strong interaction with DCrk (Balagopalan
et al., 2006; Ishimaru et al., 2004), this region is not required for
MBC function in the embryonic musculature (Balagopalan et
al., 2006). Thus, the canonical Crk-associated CDM pathway
that has been described for other organisms and used in other
Drosophila tissues (Bourne, 2005; Ishimaru et al., 2004; Reif
and Cyster, 2002) does not appear to be used in Drosophila
myoblast fusion. This finding raised the broader question of
whether other components of the canonical pathway functioned
along with MBC in the embryonic muscle, or whether MBC
functions in this tissue through different protein interactions.
To address the involvement of Drosophila ELMO in
signaling from MBC, we have isolated and characterized its
role in myoblast fusion, border cell migration and ommatidial
organization. Herein we demonstrate that ELMO is expressed in
the ovary, where it interacts genetically with MBC and plays a
role in border cell migration. We generate and analyze multiple
loss-of-function alleles to demonstrate the importance of
maternal and zygotic ELMO in myoblast fusion. We confirm,
through a targeted mass spectrometry approach, that these
proteins form a stable complex in the embryonic musculature.
We demonstrate that ELMO and MBC act cooperatively in the
mesoderm, such that an excess of both causes serious defects in
myoblast fusion reminiscent of those seen with excess Rac
activity. Finally, we establish genetically that ELMO and MBC
can cooperate to activate Rac GTPases in the adult eye.
Materials and methods
Drosophila stocks
Fly stocks were raised on standard cornmeal medium at 25 °C unless
otherwise indicated. Oregon R was used as the wild-type strain. Fly stocks that
were obtained from the Bloomington Stock Center include UAS-mCD8-GFP,
c306-GAL4, UAS-RacN17, PBac[c06760]/CyO, and Df(2L)Prl/CyO. The UAS-
elmoIR, UAS-mbcIR and UAS-DCrkIR transgenic lines were obtained from Ryu
Ueda (Ishimaru et al., 2004). UAS-elmo and UAS-elmoHA were generated by
standard methods and injected by Genetic Services, Inc. UAS-mbc and UAS-
mbcHA have been described (Balagopalan et al., 2006). For analysis of the
border cell migration phenotype, slbo-Gal4; UAS-mCD8-GFP or c306-Gal4
flies were crossed to UAS transgenic flies. Non-balancer progeny were fattened
overnight at 29 °C before dissection.
Molecular cloning of Elmo
A full length cDNA of the elmo transcript was obtained by RT-PCR from
Oregon R flies using standard methods with the forward primer
GCGCCCGGGAATGATACCAAAAAAGAC GACGG and the reverse primer
CGCGCTCGAGTTAGCTCTCAAAGCAAAAATCATAG. The resulting PCR
product was digested and cloned into the yeast 2-hybrid prey vector pGADT7
(Clontech). Full length elmo was amplified by PCR and cloned into pUAST
using the forward primer ATAAGAATGCGGCCGCAATGATACCAAAAAA-
GACGACGG and the reverse primer GCTCTAGAGTTAGCTCTCAAAG-
CAAAAATC. For the HA-tagged UAS-elmo construct, sequences encoding the
HA epitope were added to the 3′ end. All clones were verified by sequencing.
In situ hybridization and immunohistochemistry
Embryos were collected on agar-apple juice plates and aged at 25 °C. For in
situ analysis, full-length elmo was transcribed with Sp6 using the DIG mRNA
labeling kit (Roche) and hybridized as described (Tautz and Pfeifle, 1989).
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Ovary dissections and immunofluorescence staining were performed as in
Geisbrecht et al. (Geisbrecht and Montell, 2004). Antisera to ELMO was
generated in rabbit using full length protein overexpressed in bacteria and used
at 1:10. It was detected fluorescently using Alexa Fluor® 488 goat anti-rabbit
IgG at 1:400 (Molecular Probes, Carlsbad, CA). 0.5 mg/ml DAPI (Sigma,
Dallas, TX) and Alexa Fluor® 546-phalloidin at 1:400 (Molecular Probes,
Carlsbad, CA) were added with the secondary antibodies.
Yeast 2-hybrid assays
The yeast 2-hybrid screen was performed by PanBionet Inc. Full length
elmo cDNA was cloned as above and yeast 2-hybrid experiments to confirm
this interaction were performed as in Balagopalan et al. (Balagopalan et al.,
2006).
Mass spectrometry
For both MBC and ELMO, HA-tagged and untagged transgenic flies were
crossed to mef2-GAL4 females and 6–18 h embryos were collected on agar-
apple juice plates at 25 °C. For each immunopreicitation experiment, ~300 mg
embryos were dechorionated and homogenized in lysis buffer [60 mM Tris (pH
7.5), 80 mM NaCl, 6 mM EDTA (pH 8.0), 2% Triton X-100, 1 mM Na3VO4,
5 mM 1-Naphthyl phosphate potassium salt, 2 mM PMSF, 2 μg/ml Leupeptin,
2 μg/ml Pepstatin]. The NaCl concentration was increased to 300 mM and
resulting lysate mixed with anti-HA resin overnight at 4 °C. The resin was
washed 3 times with wash buffer [60 mM Tris (pH 7.5), 300 mM NaCl, 6 mM
EDTA (pH 8.0), 1.0% Triton X-100] with protease inhibitors. Protein was eluted
from the resin using 0.2 mg/ml 2× HA peptide. Samples were TCA-precipitated
and digested as described (Florens and Washburn, 2006). Peptide digests were
separated on 3-phase (reverse-phase/strong cation exchange/ reverse phase)
chromatography microcapillary columns (McDonald et al., 2002), and analyzed
by Multidimensional Protein Identification Technology (MudPIT) (Washburn et
al., 2001). Tandem mass (MS/MS) spectra were matched using SEQUEST (Eng
et al., 1994) to peptides from a database of 35050 amino acid sequences,
consisting of 17348 D. melanogaster proteins (non-redundant entries from
NCBI 2006-11-28 release) and, to estimate false discovery rates, 17525
randomized sequences for each non-redundant protein entry. Peptide/spectrum
matches were selected and compared using DTASelect/CONTRAST (Tabb et
al., 2002) and were retained if they had a DeltCn of at least 0.08. Peptides had to
be at least 7 amino acids long and their termini had to comply with the
proteolytic enzyme selectivities. For trypsin digests, minimum cross-correlation
scores (Xcorr) were set at 1.8 for singly-, 2.0 for doubly-, and 3.0 for triply-
charged spectra, while for elastase digests, minimumXCorr were 2.5 for doubly-
, and 3.5 for triply-charged spectra. Combining all runs, proteins had to be
detected by at least 2 such peptides, or 1 peptide with 2 independent spectra. To
estimate relative protein levels, Normalized Spectral Abundance Factors
(NSAFs) were calculated for each non-redundant protein, as described in
(Paoletti et al., 2006; Zybailov et al., 2006).
Generation and molecular characterization of elmo alleles
Isogenized b1elA1rdspr1 cn1or49h (Bloomington Stock Center) males were
treated with 25 mM EMS in 5% sucrose for 18–24 h using standard methods,
and the mutagenized males mated with Gla/CyO, GAL4-twi, P{UAS-2xEGFP]
virgin females. Approximately 5000 CyO-balanced male progeny were mated
individually to PBac[c06760]/CyO females. Stable stocks were generated from
crosses that failed to complement, and balanced with Gla/CyO, GAL4-twi, P
{UAS-2xEGFP]. For each EMS allele, the elmo genomic region was amplified
by PCR from heterozygous flies using elmo-specific primers and the PCR
products sequenced to identify the molecular lesion. All mutations were
confirmed in multiple sequencing reactions from independently amplified DNA
samples. For RT-PCR, RNA from appropriately staged material was made using
Trizol and subsequent RT-PCR was performed using elmo-specific primers by
standard methods. Df(2L)HO55 was made by P-element excision of the
Bloomington stock 10539 in the downstream gene aats-thr. Removal of elmo
was confirmed by PCR.Generation of germ line and mosaic clones and RNAi analysis
The elmoPB, elmo8C6, and elmo19F3 mutations were recombined onto the
FLP recombination target (FRT)-containing second chromosome of w; al1 dp
ov1 b1 pr1 P{ry[+t7.2]=neoFRT}40A (Bloomington Stock Center) and mated to
males of the genotype hs-FLP22; P{ry[+t7.2]=neoFRT}40A, P{ovoD1}/CyO.
Progeny from this cross were heat shocked at 37 °C for 2 h on days 4 and day 5
(late L2 or L3) as described (Balagopalan et al., 2006) . Female progeny of the
genotype hs-FLP22/+; P{ry[+t7.2]=neoFRT}40A, P{ovoD1}/ P{ry[+t7.2]=
neoFRT}40A, elmo* were recovered and crossed to Df(2L)Prl/ CyO, GAL4-twi,
P{UAS-2xEGFP] heterozygous males. The muscle pattern of embryos laid by
these females was then examined as described above. For mosaic clonal
analysis, larvae of the genotype hs-FLP22/+; P{ry[+t7.2]=neoFRT}40A, P
{ovoD1}/ P{ry[+t7.2]=neoFRT}40A, elmo19F3, ubiGFP were heat shocked as
described (Niewiadomska et al., 1999). The ovaries of female progeny of the
appropriate genotype were then dissected and examined as described above. For
RNAi analysis in embryos, the progeny of mef2-GAL4 or mef2-GAL4/2x UAS-
elmoIR were grown at, 29 °C until stage 16, immunostained with MHC as
above, and unfused myoblasts were counted in hemisegments A1–A5.
Scanning Electron Microscope (SEM) analysis
Scanning electron micrographs of the eyes of adult flies of the correct
genotype were taken using the Hitachi Tabletop Microscope TM-1000
according to manufacturer's suggestions.Results
Identification of ELMO as a binding partner for MBC in the
Drosophila musculature
The SH3 domain of MBC is required during Drosophila
muscle development (Balagopalan et al., 2006). We therefore
used this domain as bait in a yeast two-hybrid screen of a
Drosophila embryonic cDNA library to identify binding
partners that may function with MBC in myoblast fusion.
This screen resulted in the identification of CG5336, the Dro-
sophila ortholog of ELMO/CED-12. The interaction between
full length MBC, or MBC that lacks all proline rich regions, and
full length ELMO was confirmed in a yeast two-hybrid assay
(Fig. 1A). It was also confirmed by immunoprecipitation of
lysate from S2 cells co-transfected with full length HA-tagged
MBC and Flag-tagged ELMO in an analysis similar to that of
Ishimaru et al. (Ishimaru et al., 2004)(data not shown).
In previous studies, similar assays had revealed a robust
interaction between MBC and DCrk that is not required for
MBC-mediated signaling in myoblast fusion (Balagopalan et
al., 2006). Thus, as a first step in determining the relevance of
the above MBC/ELMO complex in the embryonic musculature,
we chose to use a proteomics analysis of MBC interactions in
this tissue. Flies transgenic for either HA-tagged or untagged
MBC under UAS control were crossed to flies bearing the
muscle-specific mef2-GAL4 driver, and lysates prepared from
the resulting embryos at approximately 6–18 h AEL. Both
transgenes are functional and rescue the myoblast fusion
phenotype when expressed in the mesoderm of mbc mutant
embryos (Balagopalan et al., 2006). HA-tagged MBC and
associated proteins were then immunoprecipitated with anti-HA
resin, and proteins in the immunoprecipitate analyzed in a silver
stained gel, by western blot and by Multidimensional Protein
Fig. 1. Identification of ELMO as a binding partner for MBC. (A) Yeast two-hybrid assay. Growth on selective media is shown on the lower panel where both full-
length and truncated MBC exhibit interaction with ELMO. (B, C) Anti-HA immunoprecipitates from lysates of untagged and HA-tagged MBC (B) and ELMO (C)
expressed in the Drosophila mesoderm under control of mef2-GAL4. (B) The silver stained gel (left panel) shows a band of ∼83 kDa that co-precipitates with MBC-
HA. This band is revealed as ELMO by mass spectrometry and Western blotting with an antisera against ELMO (right panel). (C) The silver stained gel (left panel)
shows a band of ∼200 kDa that co-precipitates with ELMO-HA. This band is identified as MBC by mass spectrometry and Western blotting with an antisera against
MBC (right panel).
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burn et al., 2001). In control samples, lysate from untagged
MBC was subjected to identical immunoprecipitation and
analysis.
As shown in Fig. 1B, a band corresponding to the expected
molecular weight of ELMO was detected in a silver stained gel
of total protein immunoprecipitated from lysates containing
HA-tagged MBC but not untagged MBC. Immunobloting
confirmed this result, detecting a strong band in the immuno-
precipitate from HA-tagged MBC. A small amount of ELMO
was also present in the control immunoprecipitate, and appeared
to be due to nonspecific sticking of MBC to the HA-resin. In the
proteomic analysis of the immunoprecipitates, shown in Table
1, ELMO was the most abundant protein detected in all MBC-
HA runs aside from MBC itself. To further substantiate this
interaction, reciprocal immunoprecipitations utilized embryos
in which HA-tagged or untagged ELMO transgenes were
expressed in the mesoderm under mef2-GAL4 control. WhileTable 1
Identification of interacting proteins by MudPIT analysis
MBC-interacting proteins
Protein Ti_1 Ti_2 Ti_3 Ti_4 Ti
MBC 27.7%a (164) b 4.4% (6) 28.8% (202) 49.2% (448) 5.
CED-12 26.9% (61) 5.4% (4) 33.0% (84) 45.3% (131) 1.
CRK 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.
CED-12 interacting proteins
Protein Ti_1 Ti_2 Ti_3 Ti_4 Ti
CED-12 42.5%a (2043)b 69.7% (1151) 74.5% (1985) 50.1% (2923) 70
MBC 7.2% (89) 27.4% (118) 39.3% (244) 27.9% (398) 31
CRK 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0
a Sequence coverage, percentage of the protein sequence covered by detected pep
b Spectral counts, total spectra matching peptides detected by tandem mass spectrthe presence of MBC was not as apparent in total immunopre-
cipitated protein analyzed by silver staining, immunoblotting
revealed a strong band that cross reacted with antisera against
MBC. In samples analyzed by mass spectrometry, MBC was
detected in all HA-ELMO immunoprecipitates, with spectral
counts corresponding to the most abundant peptides detected
after ELMO (Table 1). As anticipated from our previous studies,
DCrk was not detected in samples of immunoprecipitated MBC
or ELMO analyzed by MudPIT, nor were these proteins
detected in samples of HA-tagged DCrk expressed in the
embryonic musculature.
ELMO is expressed ubiquitously during oogenesis and
embryogenesis
To examine the temporal expression pattern of elmo mRNA,
RT-PCR was performed at various stages throughout Droso-
phila development (Fig. 2A). Much like mbc, the elmo_5 Ti_6 Es_1 EC_1 Merged controls
3% (10) 11.6% (30) 11.2% (18) 6.2% (16) 1.7% (2)
8% (1) 11.3% (9) 2.1% (1) 0.0% (1) 0.0% (0)
0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
_5 Es_1 Es_2 Es_3 Merged controls
.7% (2923) 71.1% (867) 73.8% (790) 65.5% (432) 1.8% (2)
.3% (245) 25.4% (112) 8.4% (18) 2.3% (5) 0.0% (0)
.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
tides identified by tandem mass spectroscopy Ti= trypsin.
oscopy Es=elastase EC=endoproteinase Glu-C.
Fig. 2. Temporal and spatial expression patterns of elmo. (A) Temporal expression of mbc and elmo transcript by RT-PCR at specific developmental stages in the
Drosophila life cycle. (B–C′) Immunoreactivity of ELMO antisera in wild-type ovarioles. (B) ELMO is high in the germline at all stages of ovariole development,
and is detected in the somatic follicle cells around stage 9 (arrow). (B′) DAPI (blue) and F-actin (red) do not extensively overlap with ELMO (green). (C) ELMO
expression is ubiquitous in both the germline and somatic follicle cells of a stage 10 egg chamber, and is especially prominent in the border cells (arrow, inset). (C′)
DAPI (blue) and F-actin (red) do not overlap extensively with ELMO (green). (D–I) in situ analysis of elmo in wild-type embryos. (D) elmo is detected at stage 5,
suggesting that it is provided maternally. (E) Expression is fairly ubiquitous throughout the embryo, with mesodermal expression (arrows) becoming apparent by stage
11. (F, G) Stage 13 embryo in which expression is broad, but stronger in the gut visceral mesoderm (arrows) than in the somatic mesoderm (brackets). (H) Expression is
highest (arrow) in the visceral mesoderm at stage 16. (I) High magnification view of the somatic mesoderm showing elmo expression in the mature muscle. Lateral
views are shown in panels D–F, H–I and a dorsal view in panel G. Scale bar, 50 μM.
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nally to the embryo, as evidenced by the presence of RT-PCR
product in unfertilized eggs and embryos at 0–4 h AEL.
Expression remains relatively high throughout embryogenesis,
persists during the larval and pupal stages, and is detectable in
the adult. The spatial expression pattern of ELMO, as revealed
by antisera raised against the full length protein, is broad and
cytoplasmic in the developing Drosophila ovary (Figs. 2B–
Cʺ). It is constant in the germline and becomes evident in the
somatic follicle cells after stage 9 (Fig. 2B, arrow), with
higher expression in the border cells (Fig. 2C inset, C', arrow)
at stage 10. In the embryo, maternally-provided elmo tran-
script is high prior to stage 5, which coincides with the
beginning of zygotic transcription (Fig. 2D). It is present in
the developing mesoderm in stages 9–13 (Figs. 2E–G,
arrows) and remains detectable in both the visceral and
somatic musculature through Stage 16 (Figs. 2H, I, arrows).
Staining with polyclonal rabbit antisera against ELMO reveals
a broad temporal and spatial pattern of expression, consistent
with the results of RT-PCR and in situ hybridization (data not
shown).
Generation of EMS-induced mutations in elmo
Drosophila CG5336/ELMO has 47% overall similarity with
C. elegans CED-12 and 45–54% with the three vertebrateELMO proteins. All proteins contain the same signature
domains (Fig. 3A). The primary amino acid sequence of the
N-terminal two thirds of ELMO shares no obvious homology
with any protein domains. However, analysis of secondary
structure using a homology detection/structure prediction
program and psi-blast (http://toolkit.tuebingen.mpg.de/hhpred)
suggests that this region adopts a superhelical structure similar
to that of the ARMADILLO/HEAT repeat, and includes five
such repeats ((DeBakker et al., 2004); Mushegian and
Geisbrecht, unpublished). The PH domain is highly conserved,
and all proteins contain a single proline-rich PxxP consensus
sequence for binding to SH3 domains.
Genetic analysis of elmo was initiated using a lethal
PiggyBac insertion in the first intron (PB[c06760]; Fig. 3B).
The lethality of the insert is reverted by its excision or by
expression of a UAS-elmo transgene under control of actin-
GAL4. Molecular analysis of embryos both maternally and
zygotically mutant for PB[c06760] by RT-PCR revealed the
presence of wild-type transcript as well as two larger products
(Supp. Fig. 1). The nucleotide sequence of these larger products
indicates that the PB[c06760] insertion causes some aberrant
splicing of the primary transcript between exons 1 and 2, and
introduces a stop codon 8 amino acids downstream from the end
of exon 1. Despite this perturbation, the presence of wild-type
transcript suggests that PB[c06760] is a hypomorphic allele of
elmo. To obtain null alleles, we carried out an F2 lethal screen of
Fig. 3. CG5336 encodes ELMO/Dced-12. (A) Drosophila ELMO is the ortholog of C. elegans CED-12 and human ELMO1. The N-termini of these proteins share
predicted Armadillo repeats, while the C-terminal region contains a pleckstrin homology (PH) domain and proline-rich region. (B) The intron/exon organization of the
CG5336/elmo locus is shown. The PiggyBac transposable element PB[c06760] is located in the first intron. (C) The molecular lesions obtained in an EMS screen for
elmo mutants are indicated. (D) The molecular lesion in the EMS-induced allele elmo8C6 occurs in a conserved glycine at amino acid position 666 within the PH
domain.
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failed to complement PB[c06760]. The molecular lesions of
the resulting alleles are shown in Figs. 3C and D. Stop codons
have been introduced before the PH domain in elmo19F3 and
elmo9F4, while elmo8C6 represents a missense mutation in
which a conserved glycine has been changed to arginine.
Reduced ELMO causes defects in border cell migration
Based on the observation that mbc has a role in border cell
migration (Duchek et al., 2001), that ELMO is expressed in the
border cells, and that ELMO interacts physically with MBC, we
examined whether ELMO is also required for border cell
migration. In this process, a group of 8–10 border cells are
recruited from the anterior follicle cells during stage 9, and
migrate between the nurse cells until they reach the nurse cell/
oocyte border at stage 10 (Fig. 4A). To examine the requirement
for elmo during this migration, expression of UAS-elmo IR was
directed to the border cells using the slbo-GAL4 driver. The
RNAi-mediated reduction of mbc serves as a positive control
and, as expected, results in severe defects in border cell
migration in which approximately 40% of the stage 10 egg
chambers contain cell clusters that fail to reach the nurse cell/
oocyte border (Fig. 4B). Similar, but weaker, effects are caused
by an RNAi-mediated reduction in elmo. Two independent
transgenic lines, each expressing one copy of UAS-elmo IR,cause mild defects in which 20% of the border cells fail to
migrate completely (Fig. 4B). The penetrance of this defect
increases to 40% in the presence of two copies of UAS-elmo IR.
Co-expression of UAS-mbc IR and UAS-elmo IR transgenes
further increases the severity and penetrance of the defects, such
that 55% of the border cells fail to migrate completely. By
comparison, co-expression of UAS-DCrk IR and UAS-mbc IR
increases the observed defects in border cell migration only
slightly over those observed for each transgene alone. Similar
results were obtained when the above transgenes were driven in
the border cells using c306-Gal4 driver (data not shown).
To ensure that the RNAi effects observed in border cell
migration are due to a reduction in elmo gene function, mosaic
clones of border cells lacking all elmo expression were
generated using the elmo19F3 stop codon allele. As described
recently by others (Bianco et al., 2007), we observed severe
migration defects in border cells lacking elmo with 35%
showing no migration at all and the remaining 65% arresting
their journey when only 25% complete (Figs. 4C–F' and data
not shown).
ELMO is required for myoblast fusion
Since the MBC SH3 domain is essential for embryonic
myoblast fusion (Balagopalan et al., 2006) and this domain
interacts with ELMO, we examined whether loss of elmo
143E.R. Geisbrecht et al. / Developmental Biology 314 (2008) 137–149resulted in defects in myoblast fusion. Embryos homozygous
for elmoPB[c06760] or elmo8C6 , both of which are hypomorphic
alleles, have minor defects in which a small number of
myoblasts remain unfused and muscles are occasionally
missing (data not shown). Embryos trans-heterozygous forelmoPB[c06760] or elmo8C6 and Df(2L)HO55, a deficiency that
removes elmo, also exhibit very modest perturbations. The
overall muscle pattern is unperturbed in these embryos, but
some unfused myoblasts are present just under the muscle layer
when compared to wild-type embryos in which these unfused
myoblasts are not present (Figs. 5A, A′, C–D′). A larger
number of unfused myoblasts as well as missing muscles are
apparent in Df(2L)HO55/Df(2L)HO55 embryos (Figs. 5B, B′)
and embryos trans-heterozygous for Df(2L)HO55 and either
elmo9F4 or elmo19F3 , the latter of which contain stop codons
and are therefore likely to be protein null (Figs. 5E, F). Of note,
the unfused myoblasts are most abundant and more easily
visualized in the focal plane just below the muscle layer (Figs.
5E', F').
The presence of maternally provided transcript and the
variable penetrance of the embryonic muscle defects suggested
that the perdurance of maternal elmo mRNA and/or its protein
product may be obscuring the loss of function muscle
phenotype. To address this hypothesis, germline clones
(GLCs) were generated to eliminate both maternal and zygotic
elmo transcripts. GLCs of elmo9F4 do not survive oogenesis,
likely due to the presence of a lethal background mutation. GLC
embryos mutant for elmo19F3 die prior to myogenesis, possibly
reflecting an earlier embryonic requirement for elmo. We
therefore examined GLC embryos maternally mutant for
elmoPB[c06760] or elmo8C6 and zygotically heterozygous for Df
(2L)Prl, which removes elmo, with the hope that these
hypomorphic alleles would provide sufficient transcript for
early embryogenesis, and allow later visualization of the
musculature under conditions of reduced elmo. As shown in
Figs. 6A and B, these embryos exhibit a greater number of
missing muscles and unfused myoblasts (Figs. 6A′, B′)
compared to zygotic trans-heterozygotes of the hypomporphic
alleles elmoPB[c06760] or elmo8C6. Thus, both the maternal and
zygotic transcripts contribute to ELMO's role in the embryonic
musculature.
Given the almost ubiquitous expression of elmo, and its
requirement prior to myoblast fusion, we sought to determine
whether the myoblast fusion defects observed in elmo
mutants reflect an earlier role in muscle cell fate commitment.Fig. 4. Abrogation of elmo function results in border cell migration defects. (A)
Schematic of egg chambers at stages 8–10. Nurse cells (nc), oocyte (o) and
border cells (green) are indicated. (B) Quantification of border cell migration
defects in stage 10 egg chambers expressing the indicated RNAi transgene.
Transgene expression is driven by slbo-Gal4, in a genetic background that also
includes UAS-mCD8-GFP. The number of stage 10 egg chambers examined for
each genotype is provided. A confocal image of one representative stage 10 egg
chamber is provided for each genotype to show the migration defect. The
arrowhead in each indicates the position of the border cells. Egg chambers were
stained for GFP (green), F-actin (phalloidin, red) and DAPI (blue). (C–F′)
Mosaic analysis of elmo19F3. Confocal images of stage 10 egg chambers of
elmo19F3 (C, D) and wild-type (E, F). High magnification views of the same
border cell cluster which in the elmo19F3 mutant contain a mixture of GFP
(green) positive and GFP negative cells and show no migration (C′) and in wild-
type are all GFP negative and show complete migration (E′). (D–D′ and F–F′)
Overlap with DAPI (blue) and F-actin (phalloidin, red) do not extensively
overlap with GFP (green) expression. Arrowhead indicates the position of the
border cells. Scale bar, 50 μM.
Fig. 5. Somatic muscle phenotype of elmo zygotic mutant embryos. (A–F′) Low and high magnification views of stage 16 embryos stained immunohistochemically
with anti-MHC to reveal the muscle pattern. (A) Wild-type embryos showing the mature muscle pattern and lack of unfused myoblasts (A′). (B) Embryos homozygous
mutant for Df(2L)HO55, a deficiency that removes elmo, exhibit missing muscles and unfused myoblasts (B′). (C, D) The muscle pattern appears to be unperturbed in
transheterozygous embryos zygotically mutant for elmoPB[c06760]/Df HO55 (C) and elmo8C6/Df HO55 (D), with a few unfused myoblasts visible under the muscle
layer (C′, D′, arrows). (E, F) Muscle fibers are missing in transheterozygous embryos zygotically mutant for elmo19F3/Df HO55 (E) and elmo9F4/Df HO55 (F), and
many unfused myoblasts are apparent (E′, F′, arrows). Scale bar, 50 μM.
144 E.R. Geisbrecht et al. / Developmental Biology 314 (2008) 137–149To address this possibility, we analyzed elmo maternal and
zygotic mutants with various mesodermal markers. DMEF2 is
expressed in all developing muscle cells and is required for
their differentiation. Similar numbers of DMEF2 positive
cells are observed in both WT and elmo mutant embryos
(Figs. 6C, D), suggesting that a decrease in ELMO does not
impact their specification. Likewise, specification of founder
cells and fusion competent cells appears to have occurred
normally in elmo mutants, as visualized using antibodies
against Kruppel (Kr) and Sticks and stones (SNS), respec-
tively (Figs. 6E–H). To determine if the muscle defects
observed in elmo mutants are autonomous to the muscle and
not a result of secondary defects in other tissues, we
expressed UAS-elmo IR in the muscle under the control of
mef2-GAL4. Due to the presence of maternal load and the
variability in which RNAi works in tissues, it is not
surprising that gross defects in the final muscle pattern
were not observed. However, an approximately two-fold
increase in unfused myoblasts were observed in stage 16
embryos expressing two copies of UAS-elmo IR compared to
mef2-GAL4 control embryos at 29 °C. Presumably due to
higher temperatures which can result in minor developmental
defects, control embryos showed an average of 26.8 unfused
myoblasts (SD=9.7; n=11) in hemisegments A1–A5 as
visualized by immunofluorescence with anti-MHC (data not
shown). Embryos expressing UAS-elmo IR in the musculature
showed an average of 49.3 unfused myoblasts/A1–A5
hemisegments with a SD=9.0 (n=9) with a confidence
level of N99.0%. These data strongly suggest that the elmo-
associated defects in myoblast fusion are autonomous to the
musculature, and due to a block in fusion rather than a
decrease in properly specified cells.MBC and ELMO function in concert to disrupt myoblast fusion
Mesodermal expression of constitutively-active Rac1 has
previously been shown to have a negative impact on muscle
development, severely impairing myoblast fusion (Luo et al.,
1994). Since MBC and ELMO are predicted to function
together to activate Rac1, by analogy to their orthologs, it was
of interest to determine whether excess MBC and ELMO
collaborate to perturb myoblast fusion. The mef2-GAL4 driver
was used to direct expression of UAS-mbc, UAS-elmo, or both,
to the developing musculature. Representative embryos from
this analysis are shown in Fig. 7, and demonstrate that neither
an increase in MBC nor an increase in ELMO cause obvious
muscle perturbations (Figs. 7A–C). By contrast, an excess of
both MBC and ELMO has a profound effect on myoblast
fusion (Fig. 7D), indicating that they work together to induce
downstream events. These data are consistent with the results
of our mass spectrometry analysis, which demonstrate that
MBC and ELMO interact stoichiometrically in the muscula-
ture, and suggest that this is the functional form of the two
proteins.
MBC and ELMO function as a Rac-GEF in the developing eye
The Drosophila eye, where genetic interactions are easily
observed, has been used extensively to study proteins required
for GTPase signaling, including Rac1 and Rac2 (Hakeda-
Suzuki et al., 2002; Nolan et al., 1998). Of note, mbc was
identified as a suppressor of a rough eye phenotype induced by
excess wild-type Rac1 (Nolan et al., 1998). To test the idea that
MBC and ELMO act in concert to activate Rac in vivo, we
analyzed genetic interactions in the eye. As in the embryonic
Fig. 6. Somatic muscle phenotype and muscle cell specification of maternal/zygotic elmo mutant embryos. (A–B′) Embryos from GLCs of elmoPB[c06760] or elmo8C6,
that are zygotically elmoPB[c06760]/Df(2R)Prl (A) or elmo8C6 /Df(2R)Prl (B) exhibit a dramatic loss of muscles and increase in unfused myoblasts (A′, B′, arrows). (C–
H) Wild-type and elmoPB[c06760]/Df(2R)Prlmaternal/zygotic mutant embryos stained with anti-MEF2 (C, D) anti-Krüppel (Kr) (E, F), and anti-SNS (G, H) antibodies.
(C, D) Similar number of MEF2-expressing cells are present in stage 14 wild-type and elmo mutants. (E, F) Stage 13 wild-type and elmo mutants exhibit founder cell
positive cells as stained with the founder cell antibody Kr. (G, H) Similar staining patterns are observed with SNS antibody showing fusion competent cell fate is
preserved in stage 13 wild-type and elmo mutants. All views are lateral, with anterior to the left and dorsal to the top. Scale bar, 50 μM.
145E.R. Geisbrecht et al. / Developmental Biology 314 (2008) 137–149muscle, neither excess MBC nor excess ELMO alone have an
impact on ommatidial organization (Figs. 8A, B). However,
coincident expression of MBC and ELMO causes a rough eye
phenotype (Fig. 8C). The rough eye phenotype is suppressed by
a reduction in endogenous MBC or ELMO (Fig. 8E), con-
firming that these proteins function stoichiometrically and that
the rough eye phenotype is not due to forced interactions with
other proteins. More importantly, the rough eye phenotype
appears to reflect activation of endogenous Rac proteins by theMBC/ELMO complex, since it is sensitive to the dosage of
these GTPases (Fig. 8D).
As a final confirmation that MBC and ELMO act together to
recapitulate Rac-GEF activity, we performed an analysis similar
to that described by Huelsmann (Huelsmann et al., 2006). We
took advantage of the severe rough eye phenotype caused by
expression of RacN17, which is characterized by fused
ommatidia and missing bristles ((Fan and M., 1994); Fig. 8F,
Supp. Fig. 2). This dominant-negative form of Rac is thought to
Fig. 7. Overexpression analysis of CDM pathway members in the musculature. (A–D′) Low magnification (A–D) and high magnification (A′, B′, C′, D′) views of
stage 16 embryos expressing UAS-cDNAs under control of the pan-mesodermal mef2-GAL4 driver. (A, A′) Embryos of the genotype mef2-GAL4 show a mature
muscle pattern with no missing muscles and unfused myoblasts. (B–C′) Expression of UAS-mbc or UAS-elmo, respectively, has no effect on the muscle pattern.
(D, D′) Co-expression of UAS-elmo and UAS-mbc results in missing muscles and many unfused myoblasts. All views are lateral, with anterior to the left and
dorsal to the top. Scale bar, 50 μM.
146 E.R. Geisbrecht et al. / Developmental Biology 314 (2008) 137–149sequester free GEFs in the cell. Thus an increase in the MBC/
ELMO complex would provide additional GEF to activate Rac,
thereby suppressing the eye perturbations cased by RacN17.
Indeed, co-expression of MBC and ELMO suppresses the rough
eye phenotype caused by RacN17 (Fig. 8G, Supp. Fig. 2),
indicating that these proteins function together as a Rac-GEF.Fig. 8. Genetic interactions between mbc, elmo, and Rac alleles. (A–D, F, G) Scann
GMR-GAL4. (A, B) Overexpression of mbc or elmo has no apparent impact on eye
phenotype. (D) Removal of one copy of Rac1J11Rac2Δ suppresses the rough eye ph
ratio of abnormal:normal (A:N) ommatidia present in flies co-expressing mbc and elm
for mbc, elmo, or Rac1Rac2. Adult eyes co-expressing mbc and elmo (white bar)
decreases when heterozygous for mbcD11.2 (A: N=0.65; n=20), elmo19F3 (A: N=
examined for each genotype. See also Supp Fig. 2 (F, G) Expression of RacN17 r
expression of mbc and elmo (G). Scale bar, 200 μM.Discussion
The CDM signaling pathway in Drosophila includes the
DOCK180/CED-5 ortholog MBC. Like conventional GEFs,
DOCK180 and CED-5 contain highly conserved domains that
can bind to monomeric GTPases and contribute to theiring electron micrographs of adult eyes expressing UAS-cDNAs under control of
morphology. (C) Co-expression of mbc and elmo results in a severe rough eye
enotype, resulting in nearly wild-type eye morphology. (E) Graph depicting the
o compared to flies co-expressing mbc and elmo in a heterozygous background
exhibit a ratio of 25:1 (n=32) while the ratio of abnormal:normal ommatidia
0.51; n=20) or Rac1J11Rac2Δ (A: N=1.32; n=48). n is the number of eyes
esults in a severe rough eye morphology (F) that is suppressed by coincident
147E.R. Geisbrecht et al. / Developmental Biology 314 (2008) 137–149activation (Meller et al., 2005). However, the conserved PH-
domain that is normally present within conventional GEFs is
actually provided by a separate protein family represented by
ELMO/CED-12 (Brugnera et al., 2002; Lu et al., 2004). Thus,
one member of each of these two protein families can combine
to form an unconventional bipartite GEF. While the small
adaptor protein Crk often forms a critical component of this
complex, recent studies have suggested that both DOCK180
and MBC can function in its absence (Balagopalan et al., 2006;
Tosello-Trampont et al., 2007). Moreover, Crk has been shown
to function in pathways that are totally independent of this
bipartite GEF (Sasahara et al., 2002; Tang et al., 2005).
Reminiscent of this diversity of interactions, recent studies have
suggested that CDM and ELMO/CED-12 family proteins may
also function through independent interactions. For example,
DOCK180 is capable of activating Rac on its own and has
positive effects on cell migration and phagocytosis, albeit
enhanced by binding of ELMO (Brugnera et al., 2002; Katoh
and Negishi, 2003; Lu et al., 2004), and ELMO interacts with
radixin independent of its interaction with DOCK180 (Grimsley
et al., 2005). Drosophila MBC functions in a wide variety of
processes that include border cell migration in the ovary and
myoblast fusion in the embryo (Duchek et al., 2001; Erickson et
al., 1997) and can contribute to the activation of Rac1 in the eye
(Nolan et al., 1998). We have demonstrated herein, through its
biochemical and genetic analysis, that Drosophila elmo
functions in concert with MBC in these processes. Like
MBC, decreased levels of ELMO impair border cell migration
and myoblast fusion ((Bianco et al., 2007) and studies herein).
Moreover, MBC interacts stoichiometrically in the mesoderm
with ELMO. Coincident over-expression of this complex
impairs myoblast fusion, reinforcing the model from constitu-
tively-active Rac1 that excess active Rac1 also interferes with
myoblast fusion. Co-expression of MBC and ELMO also
impacts development of the adult eye, resulting in a rough eye
phenotype that is suppressed by decreasing endogenous levels
of Rac. These data indicate that MBC and ELMO function
together in a complex, and as a RacGEF.
ELMO is expressed and acts in concert with MBC during
various stages in Drosophila development
As discussed above, CDM family proteins are required for a
diverse array of biological processes. If ELMO functions with
MBC in these processes, one would expect it to be expressed in
a temporal and spatial pattern coincident with that of MBC.
Consistent with this expectation, RT-PCR throughout the fly life
cycle, embryonic in situ hybridizations and antibody stainings
at multiple stages of Drosophila development, reveal that elmo
is broadly expressed. Interestingly, however, the MBC/ELMO
complex may serve distinct roles in each of the tissues in which
it is expressed. MBC and ELMO are required for migration of
the border cells in the ovary (Bianco et al., 2007; Duchek et al.,
2001); however, myoblast migration appears to occur normally
in mbc mutant embryos, as the fusion competent cells in mbc
mutants can be found clustered and aligned with the founder
cellsThe CDM/ELMO(Ced-12) complexes in both vertebrate and
C. elegans function upstream of Rac as unconventional bipartite
GEFs to promote exchange of GDP for GTP in activation of
monomeric GTPases (Meller et al., 2005). Our studies support a
similar role for Drosophila MBC/ELMO. First, during omma-
tidial development, the rough eye phenotype resulting from co-
expression of MBC and ELMO can be suppressed by removing
half the gene dosage contributed by Rac1 and Rac2. Also,
overexpression of the MBC/ELMO complex is sufficient to
provide enough GEF activity to overcome the effect of its
sequestration by RacN17 in the eye. In both the musculature
and eye, expression of neither MBC nor ELMO alone has a
phenotypic consequence, yet co-expression of MBC and ELMO
phenocopies activated Rac.
Notably, embryos that are completely lacking both maternal
and zygotic elmo die before muscle development occurs,
possibly reflecting an earlier role for the protein. Interestingly,
however, the development of mutant embryos that lack both
maternally and zygotically provided mbc continues until
myogenesis (Balagopalan et al., 2006). These data suggest
that, like its vertebrate counterparts, Drosophila ELMO has
multiple binding partners. In addition to DOCK180, vertebrate
ELMOs bind to three of the five additional CDM family
members, suggesting that ELMO binding is a general feature of
these proteins (Grimsley et al., 2004; Sanui et al., 2003). Based
upon primary sequence homology, the fly genome contains at
least four potential CDM superfamily members in addition to
MBC (Cote and Vuori, 2002) The predicted transcripts of two of
these are most closely related to vertebrate DOCK9/11 and
DOCK 7/8. The Drosophila protein most closely related to
vertebrate DOCK4 has been reported as the protein product of
the sponge locus (Postner et al., 1992), but has not been studied
extensively. It remains to be seen whether Drosophila ELMO is
capable of binding to these other CDM-like molecules, and
functions in concert with them in other tissues. One such place
to examine in this regard is the embryonic CNS, where ELMO
expression is quite strong but MBC is strikingly low (Erickson
et al., 1997). Thus, alternative CDM/ELMO-like complexes
may be present and required in different tissues throughout
Drosophila development, or in the same tissues to regulate
different GTPases.
Interaction of ELMO with other proteins and CDM/ELMO
integration with other signaling pathways
The above studies, combined with recent reports of ELMO
binding to non-CDM family members, may reflect a role for
ELMO proteins in integrating signals from different pathways.
Interaction of the N-terminal region of ELMO with RhoG is
capable of translocating the ELMO/DOCK180 complex to the
membrane to regulate neurite outgrowth and cell migration
(Katoh and Negishi, 2003). Simultaneously, the N-terminal
region of ELMO can bind to both the inactive and active forms
of the ERM protein radixin (Grimsley et al., 2005). Interest-
ingly, this ELMO/radixin interaction does not affect the ability
of the ELMO/DOCK180 complex to promote Rac activation
(Grimsley et al., 2005). Hence, ELMO may be functioning at
148 E.R. Geisbrecht et al. / Developmental Biology 314 (2008) 137–149the membrane to regulate the actin cytoskeleton via Rac, while
recruiting radixin and ERM family members to perform their
recognized roles in cross-linking the actin cytoskeleton to the
plasma membrane.
In addition to Rac activation via the CDM/ELMO proteins,
the ARF (ADP-ribosylation factor) family of GTPases has been
shown to signal through Rac (D'Souza-Schorey and Chavrier,
2006). Both DOCK180 and ELMO colocalize with ARNO (an
ARF-GEF) and overexpression of mutant forms of DOCK180
and ELMO mutants block ARNO-induced Rac activation
(Santy et al., 2005). However, RhoG signaling does not seem
to be required for the ARNO-ELMO activation of Rac (Santy et
al., 2005). This suggests Rac activation is differentially
regulated in cell or tissue-specific manners or that within a
cell there are localized mechanisms defined by crosstalk
between signaling pathways that are responsible for Rac
membrane localization. Intriguingly, in the Drosophila muscu-
lature, expression of a dominant-negative ARF6 results in
myoblast fusion defects while the corresponding ARF-GEF
Loner/Schizo is required for membrane localization of Rac
(Chen et al., 2003). More work is required to see if ARF6,
Loner/Schizo, and the ELMO/MBC proteins function in a
signaling pathway in Drosophila to activate Rac.
Rac activity and myoblast fusion
Numerous studies have established a crucial role for Rac
activation in myoblast fusion. More than a decade ago, Luo and
colleagues demonstrated that a dominant-negative form of Rac1
interferes with myoblast fusion (Luo et al., 1994). A herculean
genetic analysis of the small Rac GTPases proved that the
fusion defects observed with dominant-negative Rac1 reflect
the Rac1, Rac2 loss-of-function phenotype (Hakeda-Suzuki et
al., 2002). The need for activated Rac in myoblast fusion was
further supported by the phenotype of embryos mutant for mbc
(Erickson et al., 1997) and elmo, as shown herein. Rac, in turn,
likely functions to direct rearrangement of the actin cytoskele-
ton through regulation of the Arp2/3 complex via Kette and
WAVE (Chen and Olson, 2005). Surprisingly, however,
constitutively-active forms of Rac negatively impact this
process in a manner that, on the surface, have the same
phenotypic consequence as the absence of active Rac (Luo et
al., 1994). The specific relevance of excess activated Rac1 to
normal myoblast fusion remains unclear, and we cannot rule out
that excess Rac interferes with other signaling pathways that do
not normally impact myoblast fusion. However, perturbation of
this phenotype also has the potential to uncover key
components and regulators that contribute to the normal
process.
Our data establish, for example, that monomeric Rac
GTPases are in excess, and are therefore available to be
activated when the level of the MBC/ELMO GEF complex is
increased. Under normal circumstances, then, the ability of the
cell to activate this endogenous Rac remains low. Potential
mechanisms for this include the direct regulation of MBC and/
or ELMO levels through synthesis or turnover. Though little is
known about the synthesis of either MBC or ELMO or theirlevels in the cell, it is intriguing that DOCK180 is
ubiquitinated and this modification ensures its rapid turnover
(Makino et al., 2006). Alternatively, GAPs may be present to
ensure that Rac does not remain active. Finally, the MBC/
ELMO pathway may be integrating with the loner-ARF6
associated pathway, as discussed above, in such a way that
perturbation of MBC and ELMO is impacting Rac1 activity
through components of the ARF6 pathway. Either way, the fact
that this myoblast fusion phenotype is occurring in response to
perturbation of the endogenous pathway by wild-type proteins
in a stoichiometric manner suggests that it may be possible to
modulate it in ways that provide insights into the myoblast
fusion process.
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